Home
ABOS
ABOS News

Latest Acumen Pharmaceuticals Inc. (ABOS) News on January 19, 2025

Acumen announces Phase 1 INTERCEPT-AD study publication

TipRanks

9 days ago

Acumen announces Phase 1 INTERCEPT-AD study publication

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings

GlobeNewswire

10 days ago

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings

I-Mab Leads Our Spotlight On 3 US Penny Stocks

Simply Wall St.

a month ago

I-Mab Leads Our Spotlight On 3 US Penny Stocks

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswire

2 months ago

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GuruFocus.com

2 months ago

Acumen Pharmaceuticals Inc (ABOS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Acumen Pharmaceuticals Inc Earnings Call

Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

2 months ago

Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

GlobeNewswire

2 months ago

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

GlobeNewswire

2 months ago

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality

GlobeNewswire

2 months ago

Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality

Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024

GlobeNewswire

2 months ago

Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference

GlobeNewswire

3 months ago

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

GlobeNewswire

3 months ago

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

3 US Penny Stocks With Market Caps Under $500M To Consider

Simply Wall St.

3 months ago

3 US Penny Stocks With Market Caps Under $500M To Consider

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

GlobeNewswire

4 months ago

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

MT Newswires

4 months ago

Acumen, Lonza Extend Deal to Add Manufacturing of Sabirnetug for Alzheimer's Disease

Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease

GlobeNewswire

4 months ago

Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

GlobeNewswire

4 months ago

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

GlobeNewswire

5 months ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

MT Newswires

5 months ago

UBS Lowers Price Target on Acumen Pharmaceuticals to $6 From $14, Maintains Buy Rating

Thomson Reuters StreetEvents

5 months ago

Q2 2024 Acumen Pharmaceuticals Inc Earnings Call

Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

5 months ago

Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights

Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024

GlobeNewswire

5 months ago

Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024

MT Newswires

6 months ago

Acumen Pharmaceuticals Doses First Person in Phase 1 Study of Sabirnetug for Alzheimer's Disease

Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer’s Disease

GlobeNewswire

6 months ago

Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer’s Disease

MT Newswires

6 months ago

Acumen Pharmaceuticals Says Alzheimer's Therapy Phase 1 Results Consistent With Proposed Mechanism of Action

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

GlobeNewswire

6 months ago

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

MT Newswires

6 months ago

Citigroup Starts Acumen Pharmaceuticals With Buy Rating, $7 Price Target

Acumen Pharmaceuticals to Present Patient Experience and Biomarker Insights from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

GlobeNewswire

6 months ago

Acumen Pharmaceuticals to Present Patient Experience and Biomarker Insights from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?

Insider Monkey

7 months ago

Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?

GuruFocus.com

8 months ago

Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...

Thomson Reuters StreetEvents

8 months ago

Q1 2024 Acumen Pharmaceuticals Inc Earnings Call

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

8 months ago

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire

8 months ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

MT Newswires

8 months ago

Arthur J. Gallagher Acquires Acumen Advisors

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

GlobeNewswire

8 months ago

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

MT Newswires

8 months ago

Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease

GlobeNewswire

8 months ago

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

GlobeNewswire

8 months ago

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By

Insider Monkey

9 months ago

12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

GlobeNewswire

9 months ago

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

Insider Monkey

9 months ago

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

Acumen Pharmaceuticals Collaborates with Lonza For Alzheimer’s Treatment

Exec Edge

9 months ago

Acumen Pharmaceuticals Collaborates with Lonza For Alzheimer’s Treatment

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease

GlobeNewswire

9 months ago

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease

Why Acumen Pharmaceuticals (ABOS) Stock Might be a Great Pick

Zacks

10 months ago

Why Acumen Pharmaceuticals (ABOS) Stock Might be a Great Pick

Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

10 months ago

Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Acumen Pharmaceuticals Inc Earnings Call

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

GlobeNewswire

10 months ago

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year?

Zacks

10 months ago

Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year?

Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting

GlobeNewswire

10 months ago

Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

GlobeNewswire

10 months ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

15 Best Anti-Aging Foods for Youthful Skin

Insider Monkey

10 months ago

15 Best Anti-Aging Foods for Youthful Skin

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

GlobeNewswire

10 months ago

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

GlobeNewswire

10 months ago

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

Zacks

a year ago

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

Institutional investors own a significant stake of 42% in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Simply Wall St.

a year ago

Institutional investors own a significant stake of 42% in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

GlobeNewswire

a year ago

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

GlobeNewswire

a year ago

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

InvestorPlace

a year ago

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

PEOPLES FINANCIAL SERVICES CORP. Declares First Quarter 2024 Dividend

PR Newswire

a year ago

PEOPLES FINANCIAL SERVICES CORP. Declares First Quarter 2024 Dividend

BrightView Publishes 2024 Corporate Responsibility Report

Business Wire

a year ago

BrightView Publishes 2024 Corporate Responsibility Report

The Fed Tells Banks Not to Be Shy About Asking It for Money

Bloomberg

a year ago

The Fed Tells Banks Not to Be Shy About Asking It for Money

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

BayCom Corp (BCML) Reports Decrease in Q4 Earnings Amidst Market Challenges

GuruFocus.com

a year ago

BayCom Corp (BCML) Reports Decrease in Q4 Earnings Amidst Market Challenges

CORRECTION: Summit Financial Group Reports Earnings of $1.11 Per Share for Fourth Quarter 2023

GlobeNewswire

a year ago

CORRECTION: Summit Financial Group Reports Earnings of $1.11 Per Share for Fourth Quarter 2023

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates

Zacks

a year ago

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates

3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom

InvestorPlace

a year ago

3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom

GuruFocus.com

a year ago

FVCBankcorp Inc (FVCB) Reports Mixed Results Amidst Strategic Repositioning

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

PR Newswire

a year ago

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a year ago

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Associated Press Finance

a year ago

FVCBankcorp: Q4 Earnings Snapshot

FVCBankcorp, Inc. Announces 2023 Earnings

Business Wire

a year ago

FVCBankcorp, Inc. Announces 2023 Earnings

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

Zacks

a year ago

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

Kopin Receives Initial Production Order for Advanced Surgical Information Display

Business Wire

a year ago

Kopin Receives Initial Production Order for Advanced Surgical Information Display

Associated Press Finance

a year ago

RBB: Q4 Earnings Snapshot

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

Business Wire

a year ago

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

17 Best Augmented Reality Stocks To Invest In

Insider Monkey

a year ago

17 Best Augmented Reality Stocks To Invest In

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Insider Monkey

a year ago

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

Zacks

a year ago

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

Renovaro BioSciences Releases CEO Shareholder Message

NewMediaWire

a year ago

Renovaro BioSciences Releases CEO Shareholder Message

Buy These 4 Low-Beta Stocks to Counter Market Volatility

Zacks

a year ago

Buy These 4 Low-Beta Stocks to Counter Market Volatility

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Business Wire

a year ago

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Kopin Corporation Unveils New Era of Innovation and Leadership Following NASDAQ Closing Bell Ceremony

Business Wire

a year ago

Kopin Corporation Unveils New Era of Innovation and Leadership Following NASDAQ Closing Bell Ceremony

Is Now The Time To Look At Buying Canadian Solar Inc. (NASDAQ:CSIQ)?

Simply Wall St.

a year ago

Is Now The Time To Look At Buying Canadian Solar Inc. (NASDAQ:CSIQ)?

Rackspace Technology Promotes Mark Marino to Chief Financial Officer

GlobeNewswire

a year ago

Rackspace Technology Promotes Mark Marino to Chief Financial Officer

Caledonia Mining Corporation Plc: Blanket Mine Q4 and FY 2023 Production and 2024 Guidance

GlobeNewswire

a year ago

Caledonia Mining Corporation Plc: Blanket Mine Q4 and FY 2023 Production and 2024 Guidance

3 Stocks to Profit from the Enormous Gig Economy

InvestorPlace

a year ago

3 Stocks to Profit from the Enormous Gig Economy

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

Simply Wall St.

a year ago

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS

GlobeNewswire

a year ago

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS

The Zacks Analyst Blog Highlights JAKKS Pacific, Hooker Furniture, Netflix, Skillz and Acushnet

Zacks

a year ago

The Zacks Analyst Blog Highlights JAKKS Pacific, Hooker Furniture, Netflix, Skillz and Acushnet

Zynex to Participate at the Needham Annual Growth Conference

PR Newswire

a year ago

Zynex to Participate at the Needham Annual Growth Conference

J.Jill, Inc. Reaffirms Fourth Quarter and Full Year 2023 Guidance Ahead of the 26th Annual ICR Conference

Business Wire

a year ago

J.Jill, Inc. Reaffirms Fourth Quarter and Full Year 2023 Guidance Ahead of the 26th Annual ICR Conference

SmartFinancial Sets Dates for Fourth Quarter Earnings Release and Conference Call

GlobeNewswire

a year ago

SmartFinancial Sets Dates for Fourth Quarter Earnings Release and Conference Call

Is Daktronics a Buy Right Now?

Motley Fool

a year ago

Is Daktronics a Buy Right Now?

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC

GlobeNewswire

a year ago

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC

OUT vs. CCI: Which Stock Is the Better Value Option?

Zacks

a year ago

OUT vs. CCI: Which Stock Is the Better Value Option?

Can Mixed Fundamentals Have A Negative Impact on Hamilton Beach Brands Holding Company (NYSE:HBB) Current Share Price Momentum?

Simply Wall St.

a year ago

Can Mixed Fundamentals Have A Negative Impact on Hamilton Beach Brands Holding Company (NYSE:HBB) Current Share Price Momentum?

Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Simply Wall St.

a year ago

Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Share on Social Networks: